Page 96 - Updated Work Execution Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Updated work execution program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Updated Work Execution Program Today - Breaking & Trending Today

Watch live: Tomorrow is inauguration day for US president-elect Joe Biden

Follow the inauguration ceremony and virtual parade here live. ....

United States , White House , District Of Columbia , Donald Trump , Tom Hanks , Dick Brass , Joe Biden , Jennifer Lopez , Demi Lovato , Muriel Bowser , Bruce Springsteen , George Washington , Jill Biden , Justin Timberlake , Jon Bon Jovi , Barack Obama , Lady Gaga , Kerry Washington , John Legend , Eva Longoria , Kamala Harris , Presidential Inauguration Committee , Oval Office , Washington Post , National Guard , Dc National Guard ,

Servier announce updated overall survival results of exploratory TASCO1 phase II study of LONSURF + bevacizumab in a first-line setting for patients with unresectable mCRC non-eligible for intensive therapy

(2)
Servier announced today updated results from the exploratory phase II TASCO1 study evaluating LONSURF
(trifluridine/tipiracil) bevacizumab and capecitabine bevacizumab (C-B) in a first-line setting for patients with unresectable metastatic colorectal cancer (mCRC) who are non-eligible for intensive therapy.
1 The data were announced today during an oral presentation at the 2021 ASCO Gastrointestinal Cancers Symposium (ASCO-GI). Patients with mCRC who are not eligible for chemotherapy face a large unmet need, with fewer treatment options available to them and lower survival rates.
Colorectal cancer (CRC) makes up 9.7% of total global cancer cases, with almost 1.4 million new cases of CRC each year.
2 In Europe, CRC is the second most common cause of death due to cancer, and those with a metastatic disease have a 5-year survival rate of just 11%. ....

Region Flamande , United States , City Of , United Kingdom , Kostenloser Wertpapierhandel , Patrick Therasse , Eric Van Cutsem , Sonia Marques , Van Cutsem , European Medicines Agency , American Cancer Society , World Health Organisation , Cancers Symposium , Professor Eric Van Cutsem , Servier Late Stage , Life Cycle Management Oncology , Metastatic Colorectal Cancer , Taiho Pharmaceutical , Social Media , Survival Rates , Colorectal Cancer , Rev Anticancer , ஒன்றுபட்டது மாநிலங்களில் , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் , சோனியா மார்க்ஸ் ,

Welcome To IANS Live - ENTERTAINMENT - Urvashi Rautela goes '10 shades darker' for project

Photo Credit: IANS
IANSLive
Mumbai, Jan 13 (IANS) Actress and former beauty queen Urvashi Rautela has gone 10 shades darker than her original skin tone for an upcoming project.
To get full access of the story, click here to subscribe to IANS News Service
© 2021 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.
For news, views and gossips, follow IANS at Twitter.
Update: 13-January-2021 ....

Urvashi Rautela , India Private , News Service , All Rights , ஊர்வசி ரொஉதெழ , இந்தியா ப்ரைவேட் , செய்தி சேவை , அனைத்தும் உரிமைகள் ,

F. Hoffmann-La Roche Ltd: Roche to present updated data confirming Tecentriq in combination with Avastin substantially improves overall survival in people with the most common form of liver cancer

F. Hoffmann-La Roche Ltd: Roche to present updated data confirming Tecentriq in combination with Avastin substantially improves overall survival in people with the most common form of liver cancer
19.2
6.9
18.1
Tecentriq + Avastin (n=133)
24.0
(0.35-0.80)
Median follow-up: 15.6 months.
CR, complete response; DOR, duration of response; HR, hazard ratio; NE, not estimable; ORR, objective response rate; OS, overall survival; PFS, progression free response; PR, partial response; SD, stable disease.
See below for OS data from the primary analysis.
About the IMbrave150 study
IMbrave150 is a global Phase III, multicentre, open-label study of 501 people with unresectable HCC who had not received prior systemic therapy. People were randomised 2:1 to receive the combination of Tecentriq and Avastin or sorafenib. Tecentriq was administered intravenously (IV), 1200 mg on day 1 of each 21-day cycle, and Avastin was administered IV, 15 mg/kg on day ....

United States , Laura Kulik , Nathalie Meetz , Levi Garraway , Daniel Grotzky , Jon Kaspar Bayard , Karl Mahler , Sabine Borngr , Gerard Tobin , Bruno Eschli , Birgit Masjost , Lisa Tuomi , Loren Kalm , Patrick Barth , Karsten Kleine , American Society Of Clinical Oncology , Head Of Global Product Development , World Health Organisation , Roche Group , Feinberg School Of Medicine , Pharmaceuticals Industry , Roche Group Media Relations , Northwestern University , American Cancer Society , Cancers Symposium , American Society ,

Welcome To IANS Live - ENTERTAINMENT - Gauahar Khan on marriage: Happy we didn't take time to take that plunge

Photo Credit: IANS
IANSLive
New Delhi, Jan 10 (IANS) Just-married Gauahar Khan is happy that she did not waste time before taking the plunge with Zaid Darbar.
To get full access of the story, click here to subscribe to IANS News Service
© 2021 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.
For news, views and gossips, follow IANS at Twitter.
Update: 10-January-2021 ....

New Delhi , Gauahar Khan , Zaid Darbar , India Private , News Service , Just Married Gauahar Khan , All Rights , புதியது டெல்ஹி , ஸேட் தர்பார் , இந்தியா ப்ரைவேட் , செய்தி சேவை , அனைத்தும் உரிமைகள் ,